Pharmaceutical Technology ePT Weekly: Having trouble viewing this e-mail? Click here.

News Industry Briefs Webcasts Events About Us

Webcast:Improving Cell Culture Productivity: Best Practices for Automation and Control Sponsored by Parker Hannifan Webcast:Application of QWBA and Short-Lived Isotopes in the Drug Development Paradigm Sponsored by MPI Research Webcast: API Development: Risk and Control of Genotoxic Impurities Sponsored by Neuland MORE WEBCASTS Best Practices for an Effective Cleaning Validation Program February 7–8, 2013 Philadelphia, USA Informex February 19–22, 2013 California, USA   Join our online community Advertisement: Life Sciences Guidebook: Best Practices for FDA Compliance Solutions As Life Science organizations evolve, product lifecycles are speeding up to accommodate market demand and keep up with competing products. As a result, quality benchmarks need to evolve as well. Read this guide on FDA Compliance Systems and learn how your company can save time, increase your ROI and more. Learn how to select a solution, best practices for FDA compliance and Quality solutions, and tips for implementation successRead More

January 17, 2013 PharmTech.com PRINT SUBSCRIBE DIGITAL SUBSCRIBE Hameln Pharmaceuticals Receives FDA Warning Letter FDA has issued a Warning Letter to Hameln Pharmaceuticals GmbH after observing “significant” cGMP violations for finished pharmaceuticals at the company’s facility in Hameln, Germany. Lonza Expands Antibody-Drug Conjugate Manufacturing Capacity Lonza has announced a CHF14-million ($15.1 million) investment to double antibody-drug conjugate manufacturing capacity at its site in Visp, Switzerland. FDA Releases Guidance on Opioids In their effort to help industry develop abuse-deterrent opioids, FDA has released Guidance for Industry: Abuse-Deterrent Opioids—Evaluation and Labeling, Draft Guidance. EMA Updates Guideline for Anticancer Medicines The European Medicines Agency has revised its guideline for the evaluation of anticancer medicinal products. Pharma’s Reputation in Decline According to a recently conducted global survey, the overall reputation of the pharma industry declined in 2012. The African Markets Pharma can’t Ignore In its new study on pharma market growth in Africa, IMS Health highlights three ‘rising star’ countries from the continent’s sub-Saharan region. Advertisement: Together: It's how we work. It's how we help Pharma Succeed. Look to Agilent for real world solutions that help pharmaceutical companies discover more rapidly and more efficiently. The Agilent RapidFire High-throughput System and 6550 iFunnel Q-TOF mass spec helped one lab reduce a week of work to 4.5 hours, transforming their productivity. Discover more, and request your free ADME Solutions Guide at our new pharma web page: www.agilent.com/chem/togetherADME Agensys, an affiliate of Astellas Pharma, has opened a new R&D facility in Santa Monica, California. Catalent Pharma Solutions plans to make a major investment to expand its inhalation drug development, delivery, and supply capabilities by enhancing their Inhalation Center of Excellence in North Carolina. Almac is expanding its drug-product pharmaceutical-development services at its Craigavon headquarters. As of Jan. 1, 2013, the Eisai Machinery companies in Germany, China, and North America, were renamed to Bosch Inspection Technology. Read More Industry Briefs. Advertisement: INTERPHEX April 23-25, 2013 Javits Center - New York, NY INTERPHEX New York is the leading annual pharmaceutical and biopharmaceutical trade show. Taking place April 23-25, 2013 at the Javits Center in New York City you'll have the opportunity to touch and source new products from over 650 exhibitors, find solutions by networking with over 8,000 industry colleagues, and learn about the latest industry products and trends through 40+ conference sessions lead by leading subject matter experts. Register for free exhibit hall admission at: http://www.interphex.com/Advanstar

What area of the pharmaceutical industry do you think will experience the most change in 2013? Manufacturing equipment and processes 12%   Outsourcing Services 16%       Drug delivery methods 10%       Information Technology 8%       Regulation policy and enforcement 18%       Biosimilars and generics 36% This week we would like to know... What area do you think will see increased regulatory attention and enforcement in 2013? Contact Us Click here to contact editorial. Click here to contact sales.

| Subscribe | Send Feedback | Advertise With Us | Visit PharmTech.com |